Sohal Davendra P S - Division of Hematology and Oncology, University of Cincinnati

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 296 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Chemotherapy Dose Density is Prognostic for Overall Survival in Patients with Resectable Pancreas Cancer: A Landmark Analysis of SWOG 1505

Sameer H Patel,Sarah Colby,Davendra Sohal,Katherine A Guthrie, Lisa A Kachnic,E Gabriela Chiorean,Andrew M Lowy,Flavio G Rocha,Howard S Hochster,Philip A Philip,Syed A Ahmad

Cancerno. 4 (2025): e35759-e35759

Cited0Views0WOSBibtex

Early-phase Clinical Trials in the Pandemic Era: a Four-Year Experience from an Academic Cancer Center

Katie Moreland, Bethany Fuhrman, Kayla Webb, Melanie Margraf, Jessica Wernke, Christine Vollmer, Alison Kastl, Michelle Marcum, Jennifer Leddon, Amanda Jackson, Emily Curran, Shesh Rai, Trisha Wise-Draper,Davendra Sohal

American journal of cancer researchno. 2 (2025): 749-753

Cited0Views0WOSBibtex

A Phase 1/2 Study Evaluating the Safety and Efficacy of Autologous TAC T Cells in Subjects with Claudin 18.2+ Advanced Solid Tumors

Ecaterina Elena Dumbrava,Syma Iqbal, Simon Turcotte,Gregory P. Botta,Benjamin L. Schlechter,Geoffrey Yuyat Ku,Peter Joel Hosein,Samuel Saibil, Miriam Gavriliuc,Maria Apostolopoulou, Mobolaji Giwa,Kara M. Moss, Swaminathan Murugappan,Davendra Sohal

Journal of Clinical Oncologyno. 4_suppl (2025): 828-828

Cited0Views0Bibtex

A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, Plus Concurrent Chemoradiation As Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers

Andrew H Ko,Joseph Chao,Marcus S Noel,Veena Shankaran,Davendra Sohal,Mary Crow,Paul E Oberstein, Aaron J Scott,Autumn J McRee, Caio Max Sao Pedro Rocha Lima,Lawrence Fong,Bridget P Keenan,Maira Soto,Erin L Filbert,Frank J Hsu, Xiaodong Yang

Cancer research communicationsno. 2 (2025): 349-357

Cited0Views0WOSBibtex

Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Jordan M. Cloyd,Angela Sarna,Matthew J. Arango,Susan E. Bates,Manoop S. Bhutani, Mark Bloomston,Vincent Chung,Efrat Dotan,Cristina R. Ferrone, Patricia F. Gambino,Ajit H. Goenka,Karyn A. Goodman,William A. Hall,Jin He,Melissa E. Hogg,Shiva Jayaraman,Avinash Kambadakone,Matthew H. G. Katz, Alok A. Khorana,Andrew H. Ko,Eugene J. Koay,David A. Kooby,Somashekar G. Krishna, Liliana K. Larsson,Richard T. Lee,Anirban Maitra, Nader N. Massarweh,Sameh Mikhail,Mahvish Muzaffar,Eileen M. O'Reilly,Manisha Palta,Maria Q. B. Petzel,Philip A. Philip,Marsha Reyngold,Daniel Santa Mina,Davendra P. S. Sohal, Tilak K. Sundaresan,Susan Tsai, Kea L. Turner,Timothy J. Vreeland,Steve Walston,M. Kay Washington,Terence M. Williams,Jennifer Y. Wo,Rebecca A. Snyder

JAMA surgeryno. 2 (2025): 172-180

Cited0Views0WOSBibtex

Randomized Phase II Trial of Olaparib Plus Pembrolizumab Vs Olaparib Alone As Maintenance Therapy in Patients with Metastatic Pancreatic Cancer with Germline BRCA1 or BRCA2 Mutations: SWOG S2001 NCT04548752

Vincent Chung,Katherine A. Guthrie,Michael J. Pishvaian,Andrew M. Lowy,Davendra Sohal,Kim Anna Reiss,Nina Niu Sanford,Carmen Allegra,Sarah Colby,Eileen M. O'Reilly,E. Gabriela Chiorean,Philip Agop Philip

JOURNAL OF CLINICAL ONCOLOGY（2025）

Cited0Views0Bibtex

Nivolumab Plus Ipilimumab (N+I) in Patients (pts) with Pancreatic Cancer (PC) with BRCA1/2 Mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Peter Joel Hosein,Michael Rothe,Elizabeth Garrett-Mayer,Ari David Baron,Timothy Lewis Cannon,Evan P. Pisick,Evthokia Hobbs,Kathryn Finch Mileham, Matthew Joseph Tinguely,Marina Frimer,Philip Jordan Gold,Kelsey Klute,Sherise C. Rogers,Vaibhav Sahai,Davendra Sohal,Sachdev P. Thomas, Jerome Dallas Winegarden,Abby Gregory,Susan Halabi,Richard L. Schilsky

Journal of Clinical Oncologyno. 4_suppl (2025): 715-715

Cited0Views0Bibtex

An Open-Label, Multicenter Study Investigating RP2 Oncolytic Immunotherapy in Combination with Second-Line Systemic Atezolizumab Combined with Bevacizumab in Patients with Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Kevin Kim,Anwaar Saeed,Davendra Sohal,Julien Edeline,Jeong Heo, Aditya Bhansali, Shaheen Kumar,Guy Ungerechts

Journal of Clinical Oncologyno. 16_suppl (2024): TPS4191-TPS4191

Cited0Views0Bibtex

Abstract B111: Developing Prognostic Signatures (Ep-Sigs) Through Epigenetic Predictive Markers in Pancreatic Ductal Adenocarcinoma (PDA) – A Pilot Study Based on the Cancer Genome Atlas (TCGA) Data

Ashish Manne,Wancai Yang,Davendra Sohal,Ashwini Esnakula,Lianbo Yu

CANCER RESEARCHno. 2 (2024)

Cited0Views0Bibtex

First-in-Class Humanized Antibody Against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma

Clayton S. Lewis, Charles Backman, Sabahat Ahsan,Ashley Cliff,Arthi Hariharan, Jen, Xiang Zhang,Changchun Xie,Davendra P. S. Sohal,Vladimir Y. Bogdanov

International Journal of Molecular Sciencesno. 5 (2024): 2580-2580

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn